These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17114841)

  • 41. Uric acid is a useful marker to differentiate between responsive and refractory status epilepticus.
    Choi JY; Hong JM; Kim TJ; Kim BG; Huh K
    Clin Neurol Neurosurg; 2019 Sep; 184():105454. PubMed ID: 31376771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Management of adult refractory convulsive status epilepticus in the intensive care unit].
    Outin H; Liot P; De Jonghe B; Thomas P
    Rev Neurol (Paris); 2002 Nov; 158(11):1059-68. PubMed ID: 12451338
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors associated with occurrence and outcome of super-refractory status epilepticus.
    Madžar D; Knappe RU; Reindl C; Giede-Jeppe A; Sprügel MI; Beuscher V; Gollwitzer S; Hamer HM; Huttner HB
    Seizure; 2017 Nov; 52():53-59. PubMed ID: 28963934
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Refractory and Super-refractory Status Epilepticus.
    Samanta D; Garrity L; Arya R
    Indian Pediatr; 2020 Mar; 57(3):239-253. PubMed ID: 32198865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety.
    Bellante F; Legros B; Depondt C; Créteur J; Taccone FS; Gaspard N
    J Neurol; 2016 Apr; 263(4):799-806. PubMed ID: 26914931
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ketamine use in the treatment of refractory status epilepticus.
    Synowiec AS; Singh DS; Yenugadhati V; Valeriano JP; Schramke CJ; Kelly KM
    Epilepsy Res; 2013 Jul; 105(1-2):183-8. PubMed ID: 23369676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The management of status epilepticus.
    Marik PE; Varon J
    Chest; 2004 Aug; 126(2):582-91. PubMed ID: 15302747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Which anesthetic should be used in the treatment of refractory status epilepticus?
    Rossetti AO
    Epilepsia; 2007; 48 Suppl 8():52-5. PubMed ID: 18330000
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Status epilepticus and acute repetitive seizures in children, adolescents, and young adults: etiology, outcome, and treatment.
    Mitchell WG
    Epilepsia; 1996; 37 Suppl 1():S74-80. PubMed ID: 8647055
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of Refractory Status Epilepticus: An International Cohort Study (MORSE CODe) Analysis of Patients Managed in the ICU.
    Chiu WT; Campozano V; Schiefecker A; Rodriguez DR; Ferreira D; Headlee A; Zeidan S; Grinea A; Huang YH; Doyle K; Shen Q; Gómez D; Hocker SE; Rohaut B; Sonneville R; Hong CT; Demeret S; Kurtz P; Maldonado N; Helbok R; Fernandez T; Claassen J
    Neurology; 2022 Sep; 99(11):e1191-e1201. PubMed ID: 35918156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early predictors of refractory status epilepticus: an international two-center study.
    Sutter R; Kaplan PW; Marsch S; Hammel EM; Rüegg S; Ziai WC
    Eur J Neurol; 2015 Jan; 22(1):79-85. PubMed ID: 25104078
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Drug treatment of refractory status epilepticus].
    Rossetti AO; Santoli F
    Rev Neurol (Paris); 2009 Apr; 165(4):373-9. PubMed ID: 19268335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of Newer Anticonvulsants for the Treatment of Status Epilepticus.
    Farrokh S; Bon J; Erdman M; Tesoro E
    Pharmacotherapy; 2019 Mar; 39(3):297-316. PubMed ID: 30723940
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Causes and outcomes of new onset status epilepticus and predictors of refractoriness to therapy.
    Jayalakshmi S; Vooturi S; Sahu S; Yada PK; Mohandas S
    J Clin Neurosci; 2016 Apr; 26():89-94. PubMed ID: 26822381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of status epilepticus.
    Miller LC; Drislane FW
    Expert Rev Neurother; 2008 Dec; 8(12):1817-27. PubMed ID: 19086878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Unease When Using Anesthetics for Treatment-Refractory Status Epilepticus: Still Far Too Many Questions.
    Opić P; Sutter R
    J Clin Neurophysiol; 2020 Sep; 37(5):399-405. PubMed ID: 32890061
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of ketamine in refractory status epilepticus in children.
    Rosati A; L'Erario M; Ilvento L; Cecchi C; Pisano T; Mirabile L; Guerrini R
    Neurology; 2012 Dec; 79(24):2355-8. PubMed ID: 23197747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Observational study of intravenous lacosamide in patients with convulsive versus non-convulsive status epilepticus.
    Moreno Morales EY; Fernandez Peleteiro M; Bondy Peña EC; Domínguez Lorenzo JM; Pardellas Santiago E; Fernández A
    Clin Drug Investig; 2015 Jul; 35(7):463-9. PubMed ID: 26108190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Refractory status epilepticus: new insights in presentation, treatment, and outcome.
    Hocker S; Wijdicks EF; Rabinstein AA
    Neurol Res; 2013 Mar; 35(2):163-8. PubMed ID: 23336320
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clobazam: An effective add-on therapy in refractory status epilepticus.
    Sivakumar S; Ibrahim M; Parker D; Norris G; Shah A; Mohamed W
    Epilepsia; 2015 Jun; 56(6):e83-9. PubMed ID: 25963810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.